I am leaving for Russia in a little more than a week, to talk about the therapeutic use of helminths in autism at the Autism Challenges and Solutions Conference, in Moscow. Also speaking there is Dr. William Parker, one of the foremost researchers into the immunological effects of helminths. I have talked about William many times on this blog. As you know, I’ve been a fan since first reading his work back in 2010. William is covering the microbiome/autism connection at the conference so our talks are synergistic, and he actually speaks just prior to me. He’s promised me a great introduction. I’ll let you all know how he does!
Anyway, William called me a couple of nights ago to catch up and chat about our upcoming trip – but we ended up spending a good portion of an hour talking about his latest research, on the toxic effects of acetaminophen.
William asked me to share his summary of that research (see below), which was conducted with colleagues from both Duke and Harvard, and was published last month. This is simply too important for you not to know, especially if you are thinking of having a baby or have a young child. Please! – pass this on to anyone you know who may benefit!
I told William this depresses the hell out of me (Alex undoubtedly had a load given him when he was re-hospitalized at 36 hours old – more about that in a future post)…but he told me that now that they are isolating the exact mechanism by which acetaminophen does harm, it’s more likely they can come up with treatments in the future. Well…I can only live in hope.
By William Parker, PhD
Department of Surgery
Duke University Medical Center
Durham, NC 27710
Mounting data pointing at the potential for acetaminophen exposure during early childhood to induce autism in children. A review from scientists and clinicians at Duke and Harvard.
A summary of the evidence presented in the review recently published in the Journals of International Medical Research (http://journals.sagepub.com/doi/pdf/10.1177/0300060517693423) is presented here. Citations for this information can be found in the review, which is open access and contains 195 references.
(a) The epidemiology of autism matches the historic use of acetaminophen, with both rising sharply in the early 1980s following the identification of Reye Syndrome as a possible side effect of aspirin use in children.
(b) The qualitative nature of autism apparently shifted from infantile to regressive at the same time that acetaminophen use in infants and children became more popular, in the early to mid-1980s. Other than post-birth acetaminophen exposure as a major inducer of autism, no other plausible explanation for this observation is known to exist.
(c) A wide range of inflammatory conditions that affect the potential to tolerate oxidative stress are associated with autism. It is expected that these conditions will adversely affect metabolism of acetaminophen. A notable exception is cystic fibrosis, a condition of oxidative stress not known to be associated with autism. Cystic fibrosis is also unusual as a condition of oxidative stress that actually enhances rather than impairs metabolism of acetaminophen. Other than post-birth acetaminophen exposure as a major inducer of autism, no other plausible explanation for this observation is known to exist.
(d) The number of possible environmental suspects for the induction of autism at a level that would account for the epidemic is dwindling, leaving acetaminophen use in infants and small children as one of the few remaining suspects. A good suspect is one which is newly (since 1980) and widely introduced into the population, and which should be associated with a profoundly large (10-fold or greater) increase in risk of autism. Most suspects tested to date have shown moderate and sometimes variable (dependent on the population studied) associations with autism.
(e) Genetic variants associated with autism, many associated with oxidative stress, likely influence the metabolism of acetaminophen.
(f) Circumcision has been identified as a significant risk factor for autism, and the only reasonable explanation put forth for this observation is that acetaminophen use during the procedure is probably inducing autism.
(g) History demonstrates to us that it is a mistake to ignore the observations of parents when it pertains to autism. Many parents who have historically blamed vaccines for their child’s autism may have actually observed the effects of acetaminophen. In the 1990s, vaccination was advertised as the number one indication for use of acetaminophen. Other than post-birth acetaminophen exposure as a major inducer of autism, no other plausible explanation for this observation is known to exist.
(h) The idea that acetaminophen use, particularly in infants and small children, is responsible for many if not most cases of autism is an attractive hypothesis, as it satisfies Occam’s Razor in being a simple explanation that explains a wide range of observations.
Conclusions of the review:
* Our review cites 8 papers, but there are others, and more on the way.
** Additional circumstantial evidence exists, but was not cited in our review. For example, the unexplained and unusually high prevalence of autism in South Korea (https://www.ncbi.nlm.nih.gov/pubmed/21558103) just happens to occur in a country where children’s acetaminophen capsules were inadvertently overloaded with active ingredient (http://www.saul.com/sites/default/files/3591_WCW062513tcgmp.pdf).
Reblogged this on Jahn Tang and commented:
Its scary how a common pain reliever/fever drug might be the cause of autism when administered to infantile children or used during pregnancy!